Intraoperative Chemotherapy Against Hepatocellular Carcinoma Recurrence

NCT00817895 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

DRUG: sustained released 5-FU and sustained released cisplatin
DRUG: sustained released 5-FU
PROCEDURE: TACE

Sponsor

Eastern Hepatobiliary Surgery Hospital